文献速递生殖医学

不孕相关疾病卵泡液代谢特征:叙述性综述

Metabolic signature of follicular fluid in infertility-related diseases: a narrative review.
PubMed 文献 · Reprod Biomed Online · 2023-12-05

本叙述性综述检索 PubMed 上关于代谢组学与人卵泡液的研究,总结常见不孕类型(子宫内膜异位症、卵巢储备功能减退、多囊卵巢综合征)卵泡液中代谢生物标志物、动力学及其与疾病的关系,并讨论对生殖医学结局的潜在影响;作者指出需更大规模研究证实,国际数据库可能有助于改进冷冻卵母细胞选择和培养液优化。

要点

  • 子宫内膜异位症和卵巢储备功能减退患者卵泡液中葡萄糖浓度降低、乳酸和丙酮酸浓度升高。
  • 多囊卵巢综合征患者卵泡液代谢特征与上述相反。
  • 作者认为需更大规模研究证实结果,国际数据库可能有助于改进冷冻卵母细胞选择和培养液优化。

核心结论

  • 子宫内膜异位症和卵巢储备功能减退患者卵泡液呈现葡萄糖浓度降低、乳酸和丙酮酸浓度升高的代谢特征,多囊卵巢综合征患者则相反。
  • 这些特征提示子宫内膜异位症和卵巢储备功能减退患者代谢物浓度改变,以及多囊卵巢综合征患者存在有氧糖酵解降低的代谢通路改变。
  • 作者指出需更大规模研究证实结果,国际数据库可能有助于突出卵泡液生物标志物以改进冷冻卵母细胞选择,并丰富培养液以恢复正常代谢和改善生殖治疗结局。

研究设计与样本

  • 叙述性综述,检索 PubMed 上关于代谢组学与人卵泡液的出版物,识别关键生物标志物、动力学及其与不孕疾病的关系。

主要发现

  • 子宫内膜异位症和卵巢储备功能减退患者卵泡液中葡萄糖浓度降低、乳酸和丙酮酸浓度升高。
  • 多囊卵巢综合征患者卵泡液中葡萄糖浓度升高、乳酸和丙酮酸浓度降低。
  • 子宫内膜异位症和低反应患者中发现的模式也可能在育龄女性卵泡液中出现。

局限性

  • 作者指出需更大规模研究证实结果。
  • 子宫内膜异位症和低反应患者中发现的模式也可能在育龄女性卵泡液中出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metabolomics offers new methods to identify biomarkers for oocyte and embryo quality, and for a better understanding of the physiopathology of infertility. This review investigated the latest findings regarding metabolome-derived biomarkers in follicular fluid of women with the most common types of infertility, and the potential impact on reproductive medicine outcomes. PubMed was searched for publications on metabolomics and human follicular fluid, and key biomarkers, kinetics and relationships with infertility diseases were identified. A reduced concentration of glucose and increased concentrations of lactate and pyruvate were found in follicular fluid of patients with endometriosis and diminished ovarian reserve, and the opposite was found in patients with polycystic ovary syndrome. These signatures may lead to the hypothesis of changed metabolite concentrations in patients with endometriosis and diminished ovarian reserve, and a metabolic pathway alteration with decreased aerobic glycolysis in patients with polycystic ovary syndrome. However, the pattern found in patients with endometriosis and low responders may also be expected in follicular fluid of fertile women. Larger studies are needed to confirm the results. An international database may help to highlight follicular fluid biomarkers in order to improve the selection of cryopreserved oocytes, and to enrich culture medium to restore normal metabolism and improve reproductive treatment outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Fiscus J, Fraison É, Renault L, et al. Metabolic signature of follicular fluid in infertility-related diseases: a narrative review. Reprod Biomed Online. 2023. PMID: 38537523. doi:10.1016/j.rbmo.2023.103762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。